foxo4 dri senolytic peptide animal study Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging The disordered p53 transactivation domain
The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications FOXO4 DRI: Human Trial Status, Cancer Research & Senolytic Data FOXO4 DRI Peptide for Research Use My Pure Peptide Buy FOXO4 DRI (Proxofim) Senolytic Peptide For Cellular Renewal
Pay in 4 interest-free payments of $5.13 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4



